Exploratory Study of Umbilical Cord Blood-Derived CAR-NK Cell Therapy Targeting TRBC1/2 for Relapsed/Refractory T-Cell Lymphoma
Clinical trial NCT07164560 · RECRUITING
Trial details
- NCT number
- NCT07164560
- Sponsor
- Second Affiliated Hospital, Zhejiang University, School of Medicine
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-04-01
- Primary completion
- 2029-01-01
- Enrollment
- 45
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.